SNCA and Parkinson disease: Multicenter studies, optimally performed on different PD subtypes and patients in different stages of the disease, using objective measures such as PET with 18F-fluorodeoxyglucose or alpha-synuclein measurements, are needed to explore the significance of glucose trends alteration in PD.